You’ve heard a lot recently about the TypeOneNation Summit on February 25th and the experts who will be answering your questions. Take a moment to get to know more about Dr. Louis Philipson, the very definition of a type 1 diabetes (T1D) expert!
Dr. Philipson, who is an endocrinologist and a leading world authority on diabetes mellitus, has been named one of America’s “Top Doctors” by U.S. News & World Report twice in the last six years – first in 2011 and again in 2015. His presentation at TypeOneNation will focus on early diagnosis and prevention strategies.
Dr. Philipson is the founding Director of the Kovler Diabetes Center and a Clinical Center Director for Type 1 Diabetes TrialNet, an international consortium of researchers dedicated to advancing the science of prevention and early treatment to preserve residual insulin secretion in type 1 diabetes. In addition, he has been a principal investigator on numerous research projects and has been widely published in biomedical journals.
Dr. Philipson was a co-discoverer of insulin gene mutations causing neonatal diabetes, a novel class of mutations causing diabetes through beta-cell ER stress. These mutations are now known to be the second most common cause of permanent neonatal diabetes, as well as rare causes of later-onset diabetes. Dr. Philipson, together with his colleagues Drs. Graeme Bell, Siri Atma Greeley and Rochelle Naylor, established the first United States registry for monogenic diabetes including neonatal diabetes and Mature Onset Diabetes of the Young (MODY).
Talk with Dr. Philipson and all of the presenters at TypeOneNation and JDRF PEAK on February 25th at McCormick Place. Learn more about both programs and register HERE.